{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:53:28Z","timestamp":1790618008744,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10072-026-08963-z","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:46:17Z","timestamp":1775094377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroinflammation plays a crucial role in the pathogenesis of Parkinson\u2019s disease: a systematic review and meta-analysis of clinical and biomarker evidence"],"prefix":"10.1007","volume":"47","author":[{"given":"Hongfeng","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"2","key":"8963_CR1","doi-asserted-by":"publisher","first-page":"e70308","DOI":"10.1111\/cns.70308","volume":"31","author":"HX Zhu","year":"2025","unstructured":"Zhu HX, Lou WW, Jiang YM, Ciobanu A, Fang CX, Liu CY et al (2025) Histamine Modulation of the Basal Ganglia Circuitry in the Motor Symptoms of Parkinson\u2019s Disease. CNS Neurosci Ther 31(2):e70308","journal-title":"CNS Neurosci Ther"},{"issue":"25","key":"8963_CR2","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.2174\/0113816128344629250115074105","volume":"31","author":"C Zheng","year":"2025","unstructured":"Zheng C, Wu L, Luo L, Cai J, Huang Z, Tian K (2025) Therapeutic Effects and Mechanisms of Icaritin in Parkinson\u2019s Disease. Curr Pharm Des 31(25):1983\u20131989","journal-title":"Curr Pharm Des"},{"issue":"Pt 1","key":"8963_CR3","doi-asserted-by":"publisher","first-page":"141814","DOI":"10.1016\/j.ijbiomac.2025.141814","volume":"307","author":"R Zhao","year":"2025","unstructured":"Zhao R, Jia N, Wu S, Wen J, Huang Y, Zhao C et al (2025) Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson\u2019s disease. Int J Biol Macromol 307(Pt 1):141814","journal-title":"Int J Biol Macromol"},{"key":"8963_CR4","doi-asserted-by":"crossref","unstructured":"Zhang M, Lin Y, Wei H, Ju Q, Gao T, Zhang Y et al (2025) The membrane receptor CD44: roles in neurodegenerative diseases. Expert Opin Ther Targets. :1\u20131029(10):717-726","DOI":"10.1080\/14728222.2025.2563243"},{"key":"8963_CR5","doi-asserted-by":"publisher","first-page":"149893","DOI":"10.1016\/j.brainres.2025.149893","volume":"1865","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhou Y, Tian H, Li Q, Chen Y, Wang L et al (2025) NF-\u03baB signalling pathway in neurodegenerative diseases: Acupuncture as a potential therapeutic approach. Brain Res 1865:149893","journal-title":"Brain Res"},{"key":"8963_CR6","doi-asserted-by":"publisher","first-page":"106766","DOI":"10.1016\/j.jsbmb.2025.106766","volume":"251","author":"R Servi","year":"2025","unstructured":"Servi R, Akko\u00e7 RF, Aksu F, Servi S (2025) Therapeutic potential of enzymes, neurosteroids, and synthetic steroids in neurodegenerative disorders: A critical review. J Steroid Biochem Mol Biol 251:106766","journal-title":"J Steroid Biochem Mol Biol"},{"key":"8963_CR7","doi-asserted-by":"publisher","first-page":"6137521","DOI":"10.1155\/2020\/6137521","volume":"2020","author":"J He","year":"2020","unstructured":"He J, Zhu G, Wang G, Zhang F (2020) Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration. Oxid Med Cell Longev 2020:6137521","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"8963_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/mds.28004","volume":"35","author":"M Elfil","year":"2020","unstructured":"Elfil M, Kamel S, Kandil M, Koo BB, Schaefer SM (2020) Implications of the Gut Microbiome in Parkinson\u2019s Disease. Mov Disord 35(6):921\u2013933","journal-title":"Mov Disord"},{"issue":"11","key":"8963_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.tips.2020.09.002","volume":"41","author":"M Dragunow","year":"2020","unstructured":"Dragunow M (2020) Human Brain Neuropharmacology: A Platform for Translational Neuroscience. Trends Pharmacol Sci 41(11):777\u2013792","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"8963_CR10","doi-asserted-by":"publisher","first-page":"1771143","DOI":"10.1080\/2162402X.2020.1771143","volume":"9","author":"J Le Naour","year":"2020","unstructured":"Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E (2020) Trial watch: TLR3 agonists in cancer therapy. Oncoimmunology 9(1):1771143","journal-title":"Oncoimmunology"},{"issue":"12","key":"8963_CR11","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1007\/s11033-020-06033-x","volume":"47","author":"A Kumar","year":"2020","unstructured":"Kumar A, Behl T, Jamwal S, Kaur I, Sood A, Kumar P (2020) Exploring the molecular approach of COX and LOX in Alzheimer\u2019s and Parkinson\u2019s disorder. Mol Biol Rep 47(12):9895\u20139912","journal-title":"Mol Biol Rep"},{"issue":"4","key":"8963_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s13340-020-00466-2","volume":"11","author":"A Imagawa","year":"2020","unstructured":"Imagawa A, Tachibana M (2020) Fulminant type 1 diabetes: recent research progress and future prospects. Diabetol Int 11(4):336\u2013341","journal-title":"Diabetol Int"},{"key":"8963_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnint.2020.00037","volume":"14","author":"Y Guan","year":"2020","unstructured":"Guan Y, Han F (2020) Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases. Front Integr Neurosci 14:37","journal-title":"Front Integr Neurosci"},{"issue":"1","key":"8963_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jnc.15169","volume":"158","author":"MC Runtsch","year":"2021","unstructured":"Runtsch MC, Ferrara G, Angiari S (2021) Metabolic determinants of leukocyte pathogenicity in neurological diseases. J Neurochem 158(1):36\u201358","journal-title":"J Neurochem"},{"key":"8963_CR15","doi-asserted-by":"publisher","first-page":"668517","DOI":"10.3389\/fendo.2021.668517","volume":"12","author":"P Mulica","year":"2021","unstructured":"Mulica P, Gr\u00fcnewald A, Pereira SL (2021) Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective. Front Endocrinol (Lausanne) 12:668517","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"8963_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.54029\/2021nsh","volume":"26","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Guo X, Zhou Y, Zhang D, Yi X, Wang H et al (2021) Levels of serum IL6, TNF-\u03b1 and sLAG3 are changed and correlated with clinical characteristics in Parkinson\u2019s disease patients: A case-control study. Neurol Asia 26(4):709\u2013714","journal-title":"Neurol Asia"},{"issue":"2","key":"8963_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/01616412.2015.1133026","volume":"38","author":"V Gupta","year":"2016","unstructured":"Gupta V, Garg RK, Khattri S (2016) Levels of IL-8 and TNF-alpha decrease in Parkinson\u2019s disease. Neurol Res 38(2):98\u2013102","journal-title":"Neurol Res"},{"key":"8963_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clineuro.2018.01.022","volume":"166","author":"E Kouchaki","year":"2018","unstructured":"Kouchaki E, Kakhaki RD, Tamtaji OR, Dadgostar E, Behnam M, Nikoueinejad H et al (2018) Increased serum levels of TNF-alpha and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity. Clin Neurol Neurosurg 166:76\u201379","journal-title":"Clin Neurol Neurosurg"},{"key":"8963_CR19","doi-asserted-by":"publisher","first-page":"1104393","DOI":"10.3389\/fcell.2023.1104393","volume":"11","author":"J Fu","year":"2023","unstructured":"Fu J, Chen S, Liu J, Yang J, Ou R, Zhang L et al (2023) Serum inflammatory cytokines levels and the correlation analyses in Parkinson\u2019s disease. Front Cell Dev Biol 11:1104393","journal-title":"Front Cell Dev Biol"},{"key":"8963_CR20","doi-asserted-by":"crossref","unstructured":"El-Kattan MM, Rashed LA, Shazly SR, Ismail RS (2022) Relation of serum level of tumor necrosis factor-alpha to cognitive functions in patients with Parkinson\u2019s disease. Egypt J Neurol Psychiatry Neurosurg. ;58(1) :28-31","DOI":"10.1186\/s41983-022-00460-2"},{"issue":"1\u20132","key":"8963_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jneuroim.2009.08.001","volume":"216","author":"P Scalzo","year":"2009","unstructured":"Scalzo P, Kummer A, Cardoso F, Teixeira AL (2009) Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson\u2019s disease. J Neuroimmunol 216(1\u20132):122\u2013125","journal-title":"J Neuroimmunol"},{"key":"8963_CR22","doi-asserted-by":"publisher","first-page":"826013","DOI":"10.3389\/fneur.2022.826013","volume":"13","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Zhang Y, Cheng Y, Hou Y, Huang Z, Ma J et al (2022) Cerebrospinal Fluid TNF-alpha and Orexin in Patients With Parkinson\u2019s Disease and Rapid Eye Movement Sleep Behavior Disorder. Front Neurol 13:826013","journal-title":"Front Neurol"},{"key":"8963_CR23","doi-asserted-by":"crossref","unstructured":"Xiromerisiou G, Marogianni C, Lampropoulos IC, Dardiotis E, Speletas M, Ntavaroukas P et al (2022) Peripheral Inflammatory Markers TNF-alpha and CCL2 Revisited: Association with Parkinson\u2019s Disease Severity. Int J Mol Sci. ;24(1) :69\u201371","DOI":"10.3390\/ijms24010264"},{"issue":"13","key":"8963_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2174\/0113892010277933231122111244","volume":"25","author":"V Varshney","year":"2024","unstructured":"Varshney V, Kumar A, Parashar V, Kumar A, Goyal A, Garabadu D (2024) Therapeutic Potential of Capsaicin in Various Neurodegenerative Diseases with Special Focus on Nrf2 Signaling. Curr Pharm Biotechnol 25(13):1693\u20131707","journal-title":"Curr Pharm Biotechnol"},{"issue":"12","key":"8963_CR25","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.4103\/1673-5374.313015","volume":"16","author":"M Haupt","year":"2021","unstructured":"Haupt M, B\u00e4hr M, Doeppner TR (2021) Lithium beyond psychiatric indications: the reincarnation of a new old drug. Neural Regen Res 16(12):2383\u20132387","journal-title":"Neural Regen Res"},{"issue":"1","key":"8963_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","volume":"19","author":"A Heidari","year":"2022","unstructured":"Heidari A, Yazdanpanah N, Rezaei N (2022) The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease. J Neuroinflammation 19(1):135","journal-title":"J Neuroinflammation"},{"key":"8963_CR27","doi-asserted-by":"publisher","first-page":"149352","DOI":"10.1016\/j.brainres.2024.149352","volume":"1849","author":"N Mahakalakar","year":"2025","unstructured":"Mahakalakar N, Mohariya G, Taksande B, Kotagale N, Umekar M, Vinchurney M (2025) Nattokinase as a potential therapeutic agent for preventing blood-brain barrier dysfunction in neurodegenerative disorders. Brain Res 1849:149352","journal-title":"Brain Res"},{"issue":"1","key":"8963_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11033-025-10286-9","volume":"52","author":"G Kaspute","year":"2025","unstructured":"Kaspute G, Ramanavicius A, Prentice U (2025) Natural drug delivery systems for the treatment of neurodegenerative diseases. Mol Biol Rep 52(1):217","journal-title":"Mol Biol Rep"},{"issue":"1","key":"8963_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-024-00398-w","volume":"13","author":"A Sharif","year":"2024","unstructured":"Sharif A, Mamo J, Lam V, Al-Salami H, Mooranian A, Watts GF et al (2024) The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases. Transl Neurodegener 13(1):6","journal-title":"Transl Neurodegener"},{"key":"8963_CR30","doi-asserted-by":"publisher","first-page":"150046","DOI":"10.1016\/j.brainres.2025.150046","volume":"1870","author":"R Grandi","year":"2025","unstructured":"Grandi R, Gulati V, Islam MS, Ekpo O, Chitranshi N (2025) Investigating the impact of resveratrol and quercetin on glymphatic function, blood-brain barrier, and neuroglial health: A systematic review. Brain Res 1870:150046","journal-title":"Brain Res"},{"key":"8963_CR31","doi-asserted-by":"publisher","first-page":"1603292","DOI":"10.3389\/fnins.2025.1603292","volume":"19","author":"L Fu","year":"2025","unstructured":"Fu L, Luo T, Hao Z, Pan Y, Xin W, Zhang L et al (2025) Exploring novel roles of lipid droplets and lipid metabolism in regulating inflammation and blood-brain barrier function in neurological diseases. Front Neurosci 19:1603292","journal-title":"Front Neurosci"},{"issue":"10","key":"8963_CR32","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.32604\/or.2025.066805","volume":"33","author":"X Huang","year":"2025","unstructured":"Huang X, Gu R, Li Z, Wang F (2025) Igniting Cold Tumors: Multi-Omics-Driven Strategies to Overcome Immune Evasion and Restore Immune Surveillance. Oncol Res 33(10):2857\u20132902","journal-title":"Oncol Res"},{"issue":"Pt C","key":"8963_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.semcdb.2023.06.005","volume":"155","author":"AJ Kwok","year":"2024","unstructured":"Kwok AJ, Lu J, Huang J, Ip BY, Mok VCT, Lai HM et al (2024) High-resolution omics of vascular ageing and inflammatory pathways in neurodegeneration. Semin Cell Dev Biol 155(Pt C):30\u201349","journal-title":"Semin Cell Dev Biol"},{"key":"8963_CR34","doi-asserted-by":"publisher","first-page":"1526406","DOI":"10.3389\/fmed.2025.1526406","volume":"12","author":"M Zhao","year":"2025","unstructured":"Zhao M, Chang H, Yue Y, Zeng X, Wu S, Ren X (2025) The association between periodontal disease and adverse pregnancy outcomes: a bibliometric analysis from 2000 to 2023. Front Med (Lausanne) 12:1526406","journal-title":"Front Med (Lausanne)"},{"issue":"22","key":"8963_CR35","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1002\/1873-3468.70113","volume":"599","author":"C Zeyneloglu","year":"2025","unstructured":"Zeyneloglu C, Babayev H, Ogulur I, Ardicli S, Pat Y, Yazici D et al (2025) The epithelial barrier theory proposes a comprehensive explanation for the origins of allergic and other chronic noncommunicable diseases. FEBS Lett 599(22):3208\u20133243","journal-title":"FEBS Lett"},{"key":"8963_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.07.003","volume":"581","author":"S Yadav","year":"2025","unstructured":"Yadav S, Raj RG (2025) Parkinson\u2019s disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons. Neuroscience 581:1\u201315","journal-title":"Neuroscience"},{"issue":"10","key":"8963_CR37","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S et al (2024) The immune system in Parkinson\u2019s disease: what we know so far. Brain 147(10):3306\u20133324","journal-title":"Brain"},{"issue":"11","key":"8963_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"8963_CR39","first-page":"634","volume":"17","author":"CM Lill","year":"2025","unstructured":"Lill CM, Di Flora A, Sechi LA, Pereira FC, Moisoi N, Nikolovski N et al (2025) (Dys) regulation of the Immune System in Parkinson\u2019s Disease: Methodologies, Techniques, and Key Findings from Human Studies. Aging Disease 17(2):634","journal-title":"Aging Disease"},{"issue":"1","key":"8963_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.62641\/aep.v53i1.1779","volume":"53","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Fu Q, Guo X, He H, Yang G (2025) Potential Biomarkers and Treatment of Neuroinflammation in Parkinson\u2019s Disease. Actas Esp Psiquiatr 53(1):181\u2013188","journal-title":"Actas Esp Psiquiatr"},{"issue":"6","key":"8963_CR41","doi-asserted-by":"publisher","first-page":"G716","DOI":"10.1152\/ajpgi.00383.2024","volume":"328","author":"HN Templeton","year":"2025","unstructured":"Templeton HN, Tobet SA, Schwerdtfeger LA (2025) Gut neuropeptide involvement in Parkinson\u2019s disease. Am J Physiol Gastrointest Liver Physiol 328(6):G716\u2013g33","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"8963_CR42","doi-asserted-by":"publisher","first-page":"1611097","DOI":"10.3389\/fcimb.2025.1611097","volume":"15","author":"S Li","year":"2025","unstructured":"Li S, Cao H, Zhang Y, Wang F, Huang G, Wang B et al (2025) Periodontal disease and chronic kidney disease: mechanistic insights and novel therapeutic perspectives. Front Cell Infect Microbiol 15:1611097","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"8963_CR43","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1007\/s12035-024-03981-4","volume":"61","author":"Y Xu","year":"2024","unstructured":"Xu Y, Lin F, Liao G, Sun J, Chen W, Zhang L, (2024) Ripks Neuroinflammation. Mol Neurobiol 61(9):6771\u20136787","journal-title":"Mol Neurobiol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08963-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-08963-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08963-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:30:43Z","timestamp":1778308243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-08963-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8963"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-08963-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declared that they have no conflicts of interest regarding this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"399"}}